Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public ...

Scientists from CNRS have developed new stable and effective messenger RNA (mRNA) sequences that enable cells to produce therapeutic proteins themselves, capable of inducing antibody ...

Researchers at the Texas A&M University Health Science Centre have uncovered a hidden mechanism that drives the growth of one of the most aggressive forms ...

Shares of Arcturus Therapeutics Holdings fell sharply premarket amid fears about patient complications in the wake of a mid-stage trial of a biotech spray treatment for cystic fibrosis that had mixed ...

Texas A&M Health researchers discovered that RNA drives cancer growth in translocation renal cell carcinoma (tRCC) by ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

As the U.S. pulls the funding rug out from under African countries fighting infectious diseases, it is more necessary than ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.